COVID-19 reliably triggers excess mucus production in the airways, and the effect can range from a mild runny nose to dangerous mucus plugging deep in the lungs. The virus achieves this by directly ramping up mucin genes in the cells lining your respiratory tract, while simultaneously damaging the tiny hair-like cilia responsible for sweeping mucus out. The result is a double hit: more mucus being made, and less of it being cleared. As SARS-CoV-2 has evolved through successive variants, upper-airway congestion and runny nose have become increasingly common symptoms, making mucus one of the hallmarks of a modern COVID infection.
How the Virus Ramps Up Mucus Production
Your nasal passages and airways are already coated in a thin layer of mucus under normal conditions. That layer acts as a sticky trap for dust, bacteria, and viruses, and your body continuously produces and clears it without you noticing. When SARS-CoV-2 arrives, it latches onto cells using two surface proteins found throughout your nasal and bronchial lining.1PubMed Central. Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact The nasal cavity is a major initial site of infection, with high levels of the receptors the virus needs to get inside cells.2PubMed Central. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence
Once infection takes hold, the virus’s spike protein causes the goblet cells in your airway lining to crank up production of mucin proteins. Lab studies on human nasal cells showed that the spike protein alone, even without a full replication cycle, significantly increased production of the two main airway mucins.3PubMed Central. SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor Infection also triggers a wave of inflammatory signaling molecules and growth-factor signals that further amplify mucin gene activity. In cultured bronchial cells, viral levels peaked around three days after infection, but mucin production kept climbing and peaked one to two weeks later, driven by this inflammatory cascade.4PubMed Central. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease That delay helps explain why congestion and productive cough often worsen in the second week of illness, well after the viral load itself has started to drop.
Why COVID Mucus Is So Hard to Clear
Your airways have a built-in escalator system: billions of tiny cilia on the surface of airway cells beat in coordinated waves, propelling mucus (along with any trapped debris) upward toward your throat, where you swallow or cough it out. SARS-CoV-2 sabotages this system. The virus preferentially infects the multiciliated cells that drive this process, and as those cells die or lose their specialized structure, the beating slows dramatically. In lab models, bead-clearance speed on infected airway surfaces dropped from roughly 9 micrometers per second to about 1.5, and the remaining cilia lost their coordinated directionality.5Nature Communications. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
Separate experiments confirmed that by about four days after infection, the fraction of the airway surface still actively beating had fallen significantly, and the mucus being secreted by surviving goblet cells further gummed up whatever cilia remained.6Nature Communications. Live imaging of airway epithelium reveals that mucociliary clearance modulates SARS-CoV-2 spread The practical consequence is a vicious cycle: more mucus produced, less mucus removed. You feel this as persistent nasal congestion, postnasal drip, chest tightness, and a wet or productive cough that can linger for weeks.
Mucus in the Deep Lungs and Severe Disease
In mild COVID, the mucus problem stays mostly in the nose and upper airways, and most people deal with it as they would a bad cold. But in severe cases, mucus accumulation extends into the small airways and even the air sacs of the lungs, and this is where it becomes genuinely dangerous. An autopsy study found that over 90 percent of COVID-19 lung specimens showed mucus plugging in the small airways and damaged air spaces.4PubMed Central. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease In the lungs with mucus accumulation, more than half of the airway structures examined were affected. This thick mucus physically blocks gas exchange, contributing to the oxygen deprivation that defines critical COVID pneumonia.
Inflammatory cells called mast cells add to the damage in severe cases. Their activation triggers vascular leakiness and fluid buildup in the air sacs, compounding the mucus obstruction with watery edema.7PubMed Central. COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway This combination of sticky mucus and fluid-filled air sacs is what clinicians mean when they describe “diffuse alveolar damage,” and it is the pathological hallmark of fatal COVID-19 pneumonia. Researchers have noted that the mucus plugging pattern in severe COVID shares features with the airway obstruction seen in chronic lung conditions like COPD and asthma, where mucin overexpression and plugging are long-established problems.
Omicron Changed the Mucus Picture
In 2020, COVID was not known as a particularly “snotty” virus. Dry cough, fever, and loss of smell dominated early case reports, and runny nose was relatively uncommon compared to what you would expect from a cold or flu. That shifted dramatically as the virus evolved. Community surveillance data showed that when the original wild-type strain was circulating, only about 35 percent of infections involved a runny nose. By the time Omicron BA.2 became dominant, that figure had risen to roughly 71 percent. Sneezing climbed from about 36 to 60 percent, and sore throat from 40 to 62 percent over the same period.8Nature. Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern
The practical implication is that current COVID infections are far more likely to cause the kind of mucus-heavy congestion people associate with a common cold. If you caught COVID in 2024 or 2025 and your main complaint was a stuffed-up, runny nose with loads of mucus, that is now a typical presentation rather than an unusual one. The shift likely reflects Omicron’s preference for replicating in the upper airways rather than deep in the lungs, which means more nasal and sinus mucus production but, on average, less of the severe lower-airway plugging seen with earlier variants in unvaccinated people.
What the Color of Your Mucus Means (and Doesn’t)
People often worry that green or yellow mucus signals a bacterial infection requiring antibiotics, but the reality is messier than that color chart suggests. Yellow and green tints come from enzymes released by white blood cells fighting infection, and those cells show up in response to viruses just as they do to bacteria. During a straightforward COVID infection, your mucus may cycle from clear to white to yellowish and back again without any bacteria being involved.
That said, the color is not meaningless. In people with chronic lung conditions experiencing an acute flare-up, purulent (deeply yellow, green, or brownish) sputum was much more likely to harbor bacteria: only about 5 percent of purulent samples showed no bacterial growth, compared to 22 percent of mucoid (clear or white) samples.9PubMed. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease A meta-analysis of sputum color as a diagnostic test for bacteria in acute flare-ups found it had reasonable sensitivity (about 81 percent) but poor specificity (about 50 percent), meaning colored sputum catches most bacterial infections but also flags many that are not bacterial.10Annals of the American Thoracic Society. Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
The bottom line for someone with COVID: green or yellow mucus by itself does not mean you need antibiotics. But if you have colored sputum combined with worsening fever, increasing breathlessness, or symptoms that were improving and then deteriorated, a secondary bacterial infection becomes more plausible and worth discussing with a doctor. COVID infection disrupts mucosal clearance and damages the airway lining, which can create conditions favorable for bacteria to take hold.11Pneumon. Secondary bacterial infections in patients with COVID-19
When Mucus Lingers After Recovery
For most people, COVID-related mucus production winds down within two to three weeks. But a significant minority find themselves dealing with persistent cough and sputum production for months. A Japanese cohort study following COVID patients for a year found that prolonged cough and sputum at twelve months were tied to the severity of the original infection. People who had more severe acute disease, especially those who required mechanical ventilation, had the highest risk of ongoing mucus-related symptoms.12PubMed Central. Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study
This persistent mucus production falls under the broad umbrella of long COVID respiratory symptoms. The reasons likely involve lingering airway inflammation, slow regeneration of damaged ciliated cells, and possibly altered mucin gene expression that takes time to reset. If you are still coughing up mucus weeks after testing negative, it does not necessarily mean you are still infectious. It more likely reflects ongoing airway healing. That said, persistent productive cough past four to six weeks warrants a medical evaluation to rule out other explanations, including a secondary infection or an unmasked underlying condition like asthma.
Managing COVID Mucus at Home
The evidence-based options for dealing with COVID-related mucus fall into a few categories, and none of them are COVID-specific treatments. They are the same approaches used for mucus problems from any respiratory infection, adapted to the specific nuances of how SARS-CoV-2 affects the airways.
- Stay hydrated: Adequate fluid intake helps keep mucus thinner and easier to clear. There is no magic volume to target, but if your urine is dark, you are probably not drinking enough. Warm liquids like tea or broth may provide additional subjective relief by soothing irritated airways.
- Humidified air: Breathing dry air thickens mucus and slows whatever ciliary function you have left. A cool-mist humidifier in your bedroom, or simply spending a few minutes in a steamy bathroom, can make mucus easier to move. Clean the humidifier regularly to avoid introducing mold or bacteria.
- Saline nasal rinses: Rinsing your nasal passages with saline solution (either a squeeze bottle or a neti pot with distilled or boiled water) physically flushes out mucus and reduces the viral and inflammatory load in your nasal cavity. This is one of the simplest interventions and is well tolerated by most people.
- Sleeping position: Elevating your head with an extra pillow helps mucus drain downward rather than pooling in your sinuses and triggering overnight coughing fits.
Over-the-Counter and Prescription Options
Guaifenesin, the active ingredient in products like Mucinex, is the most widely used over-the-counter expectorant. It works by thinning mucus secretions, making them less sticky and easier to cough out. Clinical data support its use in conditions involving mucus hypersecretion, including upper respiratory infections and chronic bronchitis.13PubMed Central. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections Studies have shown it produces measurable improvements in sputum looseness compared to placebo.14PubMed. Guaifenesin and dextromethorphan for management of cough and mucus-related cold symptoms in adults: a narrative literature review There is also evidence that guaifenesin reduces cough-reflex sensitivity in people with upper respiratory infections, possibly by increasing sputum volume enough to physically shield the irritated nerve endings that trigger coughing.15PubMed. Effect of guaifenesin on cough reflex sensitivity
For people with thicker, more tenacious mucus or those with underlying lung conditions, N-acetylcysteine (NAC) is sometimes used. NAC breaks the chemical bonds that give mucus its gel-like structure, and it also acts as an antioxidant. It has been discussed in the context of COVID-19 treatment, both for its mucolytic properties and its potential to counter oxidative damage in the lungs.16PubMed Central. N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions NAC is available over the counter as a supplement in some countries, and by prescription as an inhaled formulation in others. The inhaled version is more directly targeted to the airways but can irritate them in some people, so it is usually used under medical supervision.
Dextromethorphan, commonly combined with guaifenesin in cold formulas, suppresses the cough reflex itself. If your cough is productive and actually moving mucus out, suppressing it too aggressively can be counterproductive. Use cough suppressants primarily for dry, non-productive coughing or for nighttime relief when the cough is disrupting sleep. During the day, a productive cough is doing useful work.
The Protective Side of Airway Mucus
It is worth understanding that mucus is not the enemy. Under normal conditions, the mucus layer in your airways is one of your primary defenses against respiratory pathogens, including SARS-CoV-2 itself. Mucin glycoproteins in the mucus layer physically trap viruses and bacteria, and the coordinated beating of cilia sweeps them out of the airways before they can establish infection.17PubMed Central. Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2 The mucus also contains antibodies, antimicrobial enzymes, and other immune molecules that neutralize pathogens on contact.
The problem in COVID is not that mucus exists but that the balance tips too far. Overproduction overwhelms the clearing system, and cilia damage means even a normal amount of mucus would stagnate. Interventions that help you manage mucus should aim to thin it and support clearance, not eliminate it entirely. This is why aggressive use of antihistamines, which dry out secretions, can sometimes backfire during a respiratory infection by making whatever mucus remains thicker and harder to move.
How Mucus Changes Contribute to Loss of Smell
One of COVID’s most distinctive symptoms, the loss of smell, turns out to have a mucus connection that most people do not expect. The olfactory region high inside your nose depends on a specialized mucus layer to function. Odor molecules dissolve in this mucus before reaching the smell receptors on olfactory nerve cells. SARS-CoV-2 infection appears to reduce and alter the mucus in this olfactory zone, impeding the ability of odor molecules to reach the receptors. Animal studies found that the quantity of olfactory mucus dropped significantly after infection.18Trends in Neurosciences. Loss of smell in COVID-19: why?
This creates an interesting paradox. While COVID causes mucus overproduction in the respiratory parts of the nose and airways, it may simultaneously reduce the specialized mucus in the olfactory cleft. The two regions are lined by different cell types with different responses to the virus. Damage to the supporting cells in the olfactory epithelium, which are responsible for producing and maintaining the olfactory mucus, appears to be a key mechanism. For many people, this loss of smell resolves as the olfactory mucus layer and its supporting cells regenerate, typically over weeks to months. In a smaller subset, the damage persists longer, contributing to the prolonged or distorted smell that some long COVID patients experience.
When Mucus Signals a Secondary Infection
Excess mucus is not just uncomfortable; it creates a breeding ground. As mentioned in the discussion of sputum color, COVID’s disruption of the mucosal barrier and ciliary clearance makes the airways more hospitable to bacteria. Viral infection increases the expression of surface receptors that bacteria use to latch onto airway cells, and stagnant mucus provides a nutrient-rich environment where bacterial colonies can form. Impaired immune-cell access within thick mucus further tips the balance.11Pneumon. Secondary bacterial infections in patients with COVID-19
Signs that a secondary bacterial infection may be developing on top of COVID include a new fever or a fever that returns after a few days of improvement, worsening cough with increasing volumes of discolored sputum, new chest pain, and increasing shortness of breath. These warrant prompt medical attention because bacterial pneumonia layered on top of viral lung damage can escalate quickly. Antibiotics have no role in treating the COVID virus itself, but they are appropriate and sometimes lifesaving when a genuine bacterial superinfection develops.